10038 |
POLY(ADP-RIBOSE) POLYMERASE 2 |
PARP2 |
ADPRT2 |
ADPRTL2 |
ADPRTL3 |
ARTD2 |
PARP-2 |
pADPRT-2 |
607725 |
272 |
ENSG00000129484 |
OTTHUMG00000166106 |
Q9UGN5 |
POLY [ADP-RIBOSE] POLYMERASE 2 |
PARP2_HUMAN |
NAD(+) ADP-ribosyltransferase 2 |
ADP-ribosyltransferase diphtheria toxin-like 2 |
hPARP-2 |
Poly[ADP-ribose] synthase 2 |
ADPRT-2 |
PARP |
POLY [ADP-RIBOSE] POLYMERASE-2 (EC 2.4.2.30) (PARP-2) (NAD(+) ADP- RIBOSYLTRANSFERASE-2) (POLY[ADP-RIBOSE] SYNTHETASE-2) (PADPRT-2) (HPARP-2). [SOURCE:UNIPROT/SWISSPROT;ACC:Q9UGN5] |
PA24592 |
T40812 |
Interpro Name | Poly(ADP-ribose) polymerase, catalytic domain |
Human Readable Name | DRUGGABLE GENOME |
Interpro Acc | IPR012317 |
Interpro Short Name | Poly(ADP-ribose)pol_cat_dom |
Uniprot Status | Swiss-Prot |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Type | Domain |
Target Class | Enzymes |
Target Subclass | EC:2.4.2.30 |
CancerCommons Reported Gene Name | PARP |
Gene Biotype | PROTEIN_CODING |
DNA REPAIR |
HISTONE MODIFICATION |
DRUGGABLE GENOME |
CLINICALLY ACTIONABLE |
inhibitor (inhibitory) |
Mechanism of Interaction | PARP 1, 2 and 3 inhibitor |
Direct Interaction | yes |
Notes |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Notes | |
Mechanism of Interaction | Poly [ADP-ribose] polymerase 2 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Poly [ADP-ribose] polymerase 2 inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | PARP 1, 2 and 3 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Poly [ADP-ribose] polymerase 2 inhibitor |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | PARP 1, 2 & 3 inhibitor |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Mechanism of Interaction | PARP 1, 2 and 3 inhibitor |
Direct Interaction | yes |
PARP2 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
PARP2 | Gene Symbol |
Target Class | Enzymes |
Target Subclass | EC:2.4.2.30 |
POLY [ADP-RIBOSE] POLYMERASE-2 (EC 2.4.2.30) (PARP-2) (NAD(+) ADP- RIBOSYLTRANSFERASE-2) (POLY[ADP-RIBOSE] SYNTHETASE-2) (PADPRT-2) (HPARP-2). [SOURCE:UNIPROT/SWISSPROT;ACC:Q9UGN5] | Description |
PARP2 | Display Id |
ENSG00000129484 | Ensembl Gene Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
10038 | Entrez Gene ID |
CancerCommons Reported Gene Name | PARP |
ENSG00000129484 | Ensembl Gene Id |
POLY [ADP-RIBOSE] POLYMERASE 2 | Uniprot Protein Name |
10038 | Entrez Gene Id |
Interpro Name | Poly(ADP-ribose) polymerase, catalytic domain |
Human Readable Name | DRUGGABLE GENOME |
Interpro Acc | IPR012317 |
DRUGGABLE GENOME |
ENSG00000129484 | Gene Symbol |
PARP2 | Ensembl Id |
DRUGGABLE GENOME |
10038 | Entrez Gene Id |
PARP2 | MyCancerGenome Gene Symbol |
PARP | MyCancerGenome Reported Gene Name |
PARP-2 | Gene Symbol |
ADPRTL2 | GENE_SYMBOL |
PARP2 | GENE_SYMBOL |
Poly [ADP-ribose] polymerase 2 | UNIPROT |
PA24592 | PharmGKB ID |
ADPRT2 | GO Gene Synonym |
ADPRTL2 | GO Gene Synonym |
DNA REPAIR, HISTONE MODIFICATION |
PARP2 | TTD Gene Abbreviation |
T40812 | TTD Target ID |
CLINICALLY ACTIONABLE |